Cartalax
Also known as: Cartalax
Cartalax is a short synthetic peptide (Ala-Glu-Asp-Gly) studied as a bioregulator for cartilage and connective tissue. It is part of the Khavinson short peptide bioregulator family.
Last updated
Mechanism of Action
Cartalax is a tetrapeptide (AEDG-related, Ala-Glu-Asp-Gly) proposed to act epigenetically by interacting with DNA and influencing gene expression in chondrocytes and bone-marrow-derived cells. Research suggests it modulates expression of genes such as those involved in cartilage matrix synthesis and can influence stem cell differentiation toward chondrogenic and osteogenic lineages. It is also reported to affect apoptosis-related signaling, supporting tissue renewal in cartilage and musculoskeletal structures.
- Half-life
- Short (minutes), typical of rapidly cleared small tetrapeptides
- Administration Routes
- subcutaneous, intramuscular
- Research Status
- Research Chemical
Reported Benefits
- Studied for support of cartilage and connective tissue
- May promote chondrocyte function and matrix synthesis
- Investigated for influence on osteo/chondrogenic stem cell differentiation
- Proposed anti-inflammatory effects in joint tissue models
- Short peptide with generally low immunogenicity
Potential Side Effects
- Limited human safety data
- Possible injection-site irritation
- Potential hypersensitivity reactions
- Unverified long-term effects
Common Dosing
For research use only and not medical advice: bioregulator protocols reference roughly 100-200 mcg daily subcutaneously or intramuscularly over 10-20 day courses; no established clinical dosing exists.
The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.
Contraindications
- Pregnancy and breastfeeding
- Known peptide hypersensitivity
- Active joint infection or acute illness without medical oversight
Cardiogen
Cardiogen is a short synthetic peptide (Ala-Glu-Asp-Arg) studied as a cardiovascular bioregulator intended to support heart and vascular tissue. It belongs to the Khavinson family of short peptide bioregulators.
Vesugen
Vesugen is a short tripeptide bioregulator studied for support of the vascular system and blood-vessel wall integrity. It is part of the Khavinson peptide family aimed at tissue-specific regulation.
Epitalon
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the pineal peptide epithalamin, studied for telomerase activation, circadian regulation, and longevity in animal and limited human research.
- View
[The influence of peptides on the chondrogenic differentiation of human mesenchymal stem cells during replicative aging.]
2023
- View
[Chondrocytes secretory phenotype associated with aging: role in the pathogenesis of osteoarthritis and prospects for peptide bioregulation.]
2023
- View
Gene expression in human mesenchymal stem cell aging cultures: modulation by short peptides
2020
- View
Peptide Regulation of Skin Fibroblast Functions during Their Aging In Vitro
2016